The global closed system transfer devices market in terms of revenue was estimated to be worth $1.1 billion in 2024 and is poised to reach $2.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Closed System Transfer Devices (CSTDs) are specialized tools designed to ensure the safe handling of hazardous drugs, particularly in healthcare settings such as pharmacies and hospitals. They provide a closed environment for the transfer of medications, preventing exposure to harmful substances for healthcare workers and reducing the risk of contamination.
Download an Illustrative overview:
In this report, the closed system transfer devices market is segmented into – closing mechanism, type, component, technology, end user, and region
Based on the closing mechanism, the market is segmented into Luer lock systems, push-to-turn systems, click-to-lock systems, and color-to-color alignment systems. In 2023, the Luer lock systems segment accounted for the highest share of 32.5% of the market. The closing mechanism’s primary role is to establish a secure connection within the CSTD system, preventing leaks and hazardous drug exposure. market. Its role in ensuring safety, user experience, and compatibility with existing systems makes it a crucial determinant of market success and growth. This directly impacts the safety of patients and healthcare workers, which is a primary driver for the CSTD.
Based on type, the CSTD market is segmented into membrane-to-membrane systems and needleless systems. In 2023, the membrane-to-membrane systems segment accounted for the largest share of 72.4% of the CSTDs market. The large share and high growth of this segment are attributed to their ease of operation and lower risk of contamination associated with double-membrane containment systems. Membrane-to-membrane systems provide a high level of safety by creating a completely sealed environment during drug transfer. This prevents any potential leakage or contamination, thereby minimizing the risk of hazardous drug exposure for healthcare workers.
Based on technology, the CSTDs market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. In 2023, the diaphragm-based devices segment accounted for the largest share of 43.0% of the market. Diaphragm-based devices are often compatible with a wide range of drug delivery systems and container closures, providing versatility for various clinical applications. This compatibility enhances their appeal to healthcare facilities seeking flexible solutions for hazardous drug handling. Thus, their effectiveness, safety, ease of use, and compatibility is expected to drive the segment growth.
Based on components, the CSTDs market is segmented into vial access components, male luers, bag spikes, female components, and other components. In 2023, the vial access components segment accounted for the largest share of 24.9% of the market. Vial access components are widely used in healthcare settings for accessing and transferring medications from vials. Also, the design of vial access components is engineered to minimize the risk of leaks, spills, and contamination during medication transfer. By providing a reliable and secure closure mechanism, they enhance the safety and efficacy of closed system transfer devices, which is a critical factor driving market preference.
Based on end users, the market is segmented into hospitals & clinics, oncology centers, and other end users. In 2023, hospitals & clinics accounted for the largest share of 82.1% of the CSTDs market. The healthcare facilities, especially hospitals and clinics, are subject to stringent regulatory standards governing the handling of hazardous drugs. Regulatory bodies like OSHA (Occupational Safety and Health Administration) in the United States mandate the use of CSTDs to protect healthcare workers from exposure to hazardous drugs. Compliance with these regulations drives the widespread adoption of CSTDs in hospitals and clinics.
North America accounted for the largest share of the closed system transfer devices market
North America accounted for the largest share of closed system transfer devices market in 2023. Owing to the continuous development and introduction of advanced CSTD technologies along with enhanced safety, efficiency, and user experience contributes to the high adoption rates of CSTDs in this region. Moreover, stringent regulations governing the handling of hazardous drugs in healthcare settings mandate the use of CSTDs to minimize the risk of exposure to hazardous drugs. Compliance with these regulations drives the demand for CSTDs in the region.
Key Market Players :
The key players in the global closed system transfer devices market include Becton, Dickinson and Company (US), ICU Medical (US), Equashield (US), Corning Incorporated (US), Simplivia Healthcare (Israel), Corvida Medical (US), Yukon Medical (US), JMS (Japan), Baxter International (US), Terumo Corporation (Japan), Cardinal Health (US), Eraser Medical (Turkey), B Braun Melsungen (Germany), West Pharmaceuticals Services (US), CODAN Medizinische Geräte GmbH & Co KG (Germany), Victus (US), Caragen (Ireland), Vygon SA (US), Practivet (US), and Insung Medical (South Korea).
Closed System Transfer Devices Market - Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall the closed system transfer devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (growth in the closed system transfer devices market in developing countries,rising cancer rates, focus on patient and worker safety, growing use of CSTDs beyond oncology, and increasing use of hazardous drugs), restraints (high cost of implementation, and limited reimbursement policies), opportunities (integration with automation, and data-driven CSTDs) and challenges (inconsistency in regulatory guidelines, and compatibility issues with certain drugs)
Market Penetration: It includes extensive information on product portfolios offered by the major players in the global the closed system transfer devices market. The report includes various segments in market closing mechanism, type, component, technology, end user, and region.
Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global the closed system transfer devices market.
Market Development: Thorough knowledge and analysis of the profitable rising markets by closing mechanism, type, component, technology, end user, and region.
Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global the closed system transfer devices market.
Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global the closed system transfer devices market.
Get 10% Free Customization on this Report:
Content Source:
https://www.marketsandmarkets.com/PressReleases/closed-system-transfer-device.asp
https://www.marketsandmarkets.com/ResearchInsight/closed-system-transfer-device-market.asp
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek